Page last updated: 2024-10-22

alprenolol and Brain Neoplasms

alprenolol has been researched along with Brain Neoplasms in 1 studies

Alprenolol: One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.
alprenolol : A secondary alcohol that is propan-2-ol substituted by a 2-allylphenoxy group at position 1 and an isopropylamino group at position 3. It is a beta-adrenergic antagonist used as a antihypertensive, anti-arrhythmia and a sympatholytic agent.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giron, LT1
Davis, JN1

Other Studies

1 other study available for alprenolol and Brain Neoplasms

ArticleYear
(-)-[3H]Dihydroalprenolol binding in subcellular fractions of rat cortex following noradrenergic denervation.
    Brain research, 1981, Oct-26, Volume: 223, Issue:1

    Topics: Alprenolol; Animals; Brain Neoplasms; Cerebral Cortex; Denervation; Dihydroalprenolol; Glioma; Kinet

1981